301393.SZ
昊帆生物
SZSE · C 制造业 · CN
CNY 61.32
−6.28%Margins
Gross margin
34.2%
EBITDA margin
28.3%
EBIT margin
22.2%
Net margin
17.7%
FCF margin
-27.4%
4.7%
Return on equity
4.0%
Return on assets
5.7%
Return on invested capital
0.23x
Asset turnover
CNY 139.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026